| Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas KW Pajtler, J Wen, M Sill, T Lin, W Orisme, B Tang, JM Hübner, ... Acta neuropathologica 136, 211-226, 2018 | 230 | 2018 |
| Radiological classification of optic pathway gliomas: experience of a modified functional classification system T Taylor, T Jaspan, G Milano, R Gregson, T Parker, T Ritzmann, C Benson, ... The British journal of radiology 81 (970), 761-766, 2008 | 137 | 2008 |
| A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and … TA Ritzmann, HA Rogers, SML Paine, LCD Storer, TS Jacques, ... Pediatric Blood & Cancer 67 (9), e28426, 2020 | 55 | 2020 |
| Tissue metabolite profiles for the characterisation of paediatric cerebellar tumours CD Bennett, SE Kohe, SK Gill, NP Davies, M Wilson, LCD Storer, ... Scientific reports 8 (1), 11992, 2018 | 24 | 2018 |
| Assessment of cannabidiol and Δ9-tetrahydrocannabiol in mouse models of medulloblastoma and ependymoma C Andradas, J Byrne, M Kuchibhotla, M Ancliffe, AC Jones, B Carline, ... Cancers 13 (2), 330, 2021 | 23 | 2021 |
| SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort—A BIOMECA Consortium Study TA Ritzmann, RJ Chapman, JP Kilday, N Thorp, P Modena, RA Dineen, ... Neuro-oncology 24 (6), 936-948, 2022 | 22 | 2022 |
| Toward improved diagnosis accuracy and treatment of children, adolescents, and young adults with ependymoma: the international SIOP ependymoma II protocol P Leblond, M Massimino, M English, TA Ritzmann, L Gandola, ... Frontiers in neurology 13, 887544, 2022 | 16 | 2022 |
| Spatial transcriptomic analysis delineates epithelial and mesenchymal subpopulations and transition stages in childhood ependymoma R Fu, GA Norris, N Willard, AM Griesinger, KA Riemondy, V Amani, ... Neuro-oncology 25 (4), 786-798, 2023 | 9 | 2023 |
| Recurrent ACVR1 mutations in posterior fossa ependymoma D Pratt, CHG Lucas, PP Selvam, Z Abdullaev, C Ketchum, M Quezado, ... Acta neuropathologica 144 (2), 373-376, 2022 | 6 | 2022 |
| Paediatric Ependymomas: destined to recur? TA Ritzmann, JP Kilday, RG Grundy Neuro-Oncology, 2021 | 6 | 2021 |
| Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study AM Donson, KC Bertrand, KA Riemondy, D Gao, Y Zhuang, B Sanford, ... Neuro-oncology 25 (10), 1854-1867, 2023 | 5 | 2023 |
| Multicentre service evaluation of presentation of newly diagnosed cancers and type 1 diabetes in children in the UK during the COVID-19 pandemic G Williams, R McLean, JF Liu, TA Ritzmann, M Dandapani, ... BMJ Paediatrics Open 5 (1), 2021 | 4 | 2021 |
| EPEN-23. A computational analysis of the tumour immune microenvironment in paediatric ependymoma T Ritzmann, A Lourdusamy, A Jackson, L Storer, A Donson, A Griesinger, ... Neuro-Oncology 22 (Supplement 3), 2020 | 3 | 2020 |
| Translating childhood brain tumour research into clinical practice: the experience of molecular classification and diagnostics TA Ritzmann, RG Grundy Paediatrics and Child Health 28 (4), 177-182, 2018 | 3 | 2018 |
| The Molecular Era of Brain Tumour Research is upon us: But what now for our Patients T Ritzmann, RG Grundy, R Rahman Journal of Brain Tumors Neurooncology, 2016 | 3 | 2016 |
| Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study RJ Chapman, DR Ghasemi, F Andreiuolo, V Zschernack, AT Espariat, ... Neuro-oncology 25 (10), 1871-1882, 2023 | 2 | 2023 |
| Spatial transcriptomic analysis of childhood ependymoma implicates unresolved wound healing as a driver of tumor progression R Fu, GA Norris, N Willard, AM Griesinger, KA Riemondy, V Amani, ... bioRxiv, 2022.03. 29.486280, 2022 | 2 | 2022 |
| Modified prone position to dissect the popliteal fossa A Boulemden, T Ritzmann, S Liptrot, A Abbas, KR Makhdoomi The Annals of The Royal College of Surgeons of England 95 (2), 110-112, 2013 | 2 | 2013 |
| Phase II study of intravenous etoposide in patients with relapsed ependymoma (CNS 2001 04) JR Apps, S Maycock, DW Ellison, T Jaspan, TA Ritzmann, D Macarthur, ... Neuro-oncology advances 4 (1), vdac053, 2022 | 1 | 2022 |
| EPEN-09. RNA-SEQ analysis of recurrent paediatric ependymomas reveals immunological changes specific to molecular subgroups RP EPENDYMOMA Neuro-oncology, 2018 | 1 | 2018 |
